In addition, zinc has been shown to suppress the metastatic potential of prostate cancer by inhibiting NF-κB signaling51,52, and suppressing the invasive potential of the proteolytic enzyme urokinase-type plasminogen activator, aminopeptidase N, and prostate specific antigen (PSA)53,54. The gene discussed is KLK3; the disease is prostate cancer.